IVF Hartmann Holding AG (SWX:VBSN)
Switzerland · Delayed Price · Currency is CHF 132.00
-6.00 (-4.35%)
Apr 24, 2026, 5:30 PM CET
IVF Hartmann Holding AG Market Cap
IVF Hartmann Holding AG has a market cap or net worth of 328.63 million as of April 24, 2026. Its market cap has decreased by -12.66% in one year.
Market Cap
328.63M
Enterprise Value
217.62M
Revenue
161.85M
Ranking
n/a
PE Ratio
18.11
Stock Price
132.00
Market Cap Chart
Since February 29, 2000, IVF Hartmann Holding AG's market cap has increased from 4.82M to 328.63M, an increase of 6,712.37%. That is a compound annual growth rate of 17.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 328.63M | -3.50% |
| Dec 30, 2025 | 340.53M | -4.68% |
| Dec 30, 2024 | 357.24M | 34.36% |
| Dec 29, 2023 | 265.89M | -6.28% |
| Dec 30, 2022 | 283.72M | -2.86% |
| Dec 30, 2021 | 292.08M | -34.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 259.45B |
| Novartis AG | 221.88B |
| Galderma Group AG | 37.70B |
| Lonza Group AG | 34.86B |
| Basilea Pharmaceutica AG | 662.52M |
| DocMorris AG | 334.10M |
| Newron Pharmaceuticals | 324.15M |
| COLTENE Holding AG | 297.57M |